Akebia Therapeutics (AKBA) Other Non Operating Income (2013 - 2026)

Akebia Therapeutics (AKBA) has 14 years of Other Non Operating Income data on file, last reported at $3000.0 in Q1 2026.

• On a quarterly basis, Other Non Operating Income fell 98.59% year-over-year to $3000.0 in Q1 2026; TTM through Mar 2026 was $23000.0, a 97.07% decrease from a year earlier, with the FY2025 full-year figure at $58000.0, down 38.3% from the prior year.
• Other Non Operating Income for Q1 2026 stood at $3000.0, down from $58000.0 in the prior quarter.
• Over the last five years, Other Non Operating Income for AKBA reached as high as $1.2 million in Q3 2022 and fell as low as -$517000.0 in Q1 2024.
• Historically, Other Non Operating Income has averaged $257714.3 across 5 years, with a median of $30500.0 in 2025.
• Across the five-year window, Other Non Operating Income surged 604.35% in 2022 and slumped 290.0% in 2024, its largest moves.
• Year by year, Other Non Operating Income stood at $1.2 million in 2022, then declined by 23.99% to $887000.0 in 2023, then sank by 31.12% to $611000.0 in 2024, then sank by 90.51% to $58000.0 in 2025, then sank by 94.83% to $3000.0 in 2026.
• Per Business Quant data, the three most recent Other Non Operating Income figures were $3000.0 in Q1 2026, $58000.0 in Q4 2025, and -$10000.0 in Q3 2025.